Americas (WHO region) vs Azerbaijan: Estimated antiretroviral therapy coverage among children
Americas (WHO region)
48
in 2025
Azerbaijan
87
in 2025
Americas (WHO region) rank
6th
Azerbaijan rank
3rd
Estimated antiretroviral therapy coverage among children over time
- Americas (WHO region)
- Azerbaijan
How they compare
Azerbaijan currently reports 87 against 48 in Americas (WHO region), a difference of 39.
That makes Azerbaijan's figure about 1.8 times Americas (WHO region)'s.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Americas (WHO region) ahead.
Americas (WHO region) ranks 6th and Azerbaijan ranks 3rd of 13 groups.
Across the 3 decades both report, Americas (WHO region) averaged higher in 2 and Azerbaijan in 1.
Head to head by decade
| Decade | Americas (WHO region) | Azerbaijan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.5 | 0.2 | 11.3 | Americas (WHO region) |
| 2010s | 38 | 34.2 | 3.8 | Americas (WHO region) |
| 2020s | 44.67 | 72.67 | 28 | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Americas (WHO region) or Azerbaijan?
- Azerbaijan, at 87 against 48 in Americas (WHO region) as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Americas (WHO region) and Azerbaijan?
- 39, with Azerbaijan ahead.
- How many years of comparable data are there for Americas (WHO region) and Azerbaijan?
- 26 years are reported by both, from 2000 to 2025.
- How do Americas (WHO region) and Azerbaijan rank globally for estimated antiretroviral therapy coverage among children?
- Americas (WHO region) ranks 6th and Azerbaijan ranks 3rd of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.